http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0341291-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_700ff9a01db2075489cb7ed87392dc28
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M1-3672
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M1-3673
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M1-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M1-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-22
filingDate 1988-11-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7c34400311b467ef8acb6050bb295465
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_71b78535151f5cbf9e23d799ba14768a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b3e28d6f5735500c5d50a3126e4e845f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9dd1adf1933e9a2fc7f951cfb4d31ba8
publicationDate 1989-11-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-0341291-A1
titleOfInvention REGULATED ADMINISTRATION OF A THERAPEUTIC AGENT WITH BLOOD.
abstract As blood is introduced into a container (12) through a conduit (10) the blood flows through the conduit through an amount of therapeutic agent (18), such as an anticoagulant, to cause administering a regulated amount of therapeutic agent to the blood stream in a substantially uniform manner over time. The therapeutic agent (18) is typically present in dry form until it comes into contact with the blood. As a result, no part of the blood is exposed to a concentration of therapeutic agent significantly higher than that to which other parts of the blood are exposed.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9357765-B2
priorityDate 1987-11-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0168522-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0059694-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-3965896-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6251
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393819
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6335613
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24749
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395791
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57199466
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226402238
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394438

Total number of triples: 29.